Novocure Ltd (NVCR)

Jun 18, 2025

NovoCure Limited's (NASDAQ:NVCR) P/S Still Appears To Be Reasonable - simplywall.st

Jun 18, 2025

Jun 16, 2025

Rhumbline Advisers Has $2.69 Million Stock Position in NovoCure Limited (NASDAQ:NVCR) - Defense World

Jun 16, 2025

Jun 12, 2025

Novocure’s SWOT analysis: innovative cancer therapy firm faces growth hurdles By Investing.com - Investing.com South Africa

Jun 12, 2025

Jun 12, 2025

Novocure’s SWOT analysis: innovative cancer therapy firm faces growth hurdles - Investing.com India

Jun 12, 2025

Jun 06, 2025

NovoCure Ltd (NVCR) Shares Up 4.08% on Jun 6 - GuruFocus

Jun 06, 2025

Jun 06, 2025

NVCR Stock Dips Despite Positive OS Data From Phase 3 PANOVA-3 Trial - TradingView

Jun 06, 2025

Jun 06, 2025

Mackenzie Financial Corp Purchases Shares of 6,820 NovoCure Limited (NASDAQ:NVCR) - Defense World

Jun 06, 2025

Jun 05, 2025

Insider Sell Alert: Frank Leonard Sells 30,196 Shares of NovoCure Ltd (NVCR) - GuruFocus

Jun 05, 2025

Jun 04, 2025

Novocure at Jefferies Conference: Expanding Horizons in Cancer Treatment - Investing.com

Jun 04, 2025

Jun 04, 2025

NovoCure Limited (NASDAQ:NVCR) Given Consensus Rating of “Moderate Buy” by Analysts - Defense World

Jun 04, 2025

Jun 03, 2025

Ameriprise Financial Inc. Has $682,000 Position in NovoCure Limited (NASDAQ:NVCR) - Defense World

Jun 03, 2025

Jun 02, 2025

H.C. Wainwright reiterates Buy rating on NovoCure stock after ASCO data - Investing.com Nigeria

Jun 02, 2025

Jun 02, 2025

NovoCure Ltd (NVCR) Shares Down 7.43% on Jun 2 - GuruFocus

Jun 02, 2025

Jun 02, 2025

NovoCure's Tumor Treating Fields Boost One-Year And Pain-Free Survival In Pancreatic Cancer Trial - Yahoo Finance

Jun 02, 2025

Jun 02, 2025

Novocure (NVCR) Gains Support for Future Launch from Promising T - GuruFocus

Jun 02, 2025

Jun 02, 2025

Novocure (NVCR) Gains Support for Future Launch from Promising Trial Outcomes | NVCR Stock News - GuruFocus

Jun 02, 2025

Jun 02, 2025

H.C. Wainwright reiterates Buy rating on NovoCure stock after ASCO data By Investing.com - Investing.com South Africa

Jun 02, 2025

Jun 01, 2025

Novocure (NVCR) Announces Positive Phase 3 Trial Results for Pancreatic Cancer Therapy | NVCR Stock News - GuruFocus

Jun 01, 2025

Jun 01, 2025

Novocure announces results from Phase 3 PANOVA-3 trial - TipRanks

Jun 01, 2025

May 31, 2025

Zai Lab and Novocure Announce Results From the Phase 3 PANOVA-3 - GuruFocus

May 31, 2025

May 31, 2025

Zai Lab and Novocure Announce Results From the Phase 3 PANOVA-3 Trial of Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer to be Presented at 2025 ASCO Annual Meeting - Lelezard

May 31, 2025

May 31, 2025

Results From the Phase 3 PANOVA-3 Trial of Novocure's Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer to be Presented at 2025 ASCO Annual Meeting | NVCR Stock News - GuruFocus

May 31, 2025

May 31, 2025

Results From the Phase 3 PANOVA-3 Trial of Novocure’s Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer to be Presented at 2025 ASCO Annual Meeting - Yahoo Finance

May 31, 2025

May 30, 2025

NovoCure Ltd (NVCR) Shares Gap Down to $18.5801 on May 30 - GuruFocus

May 30, 2025

May 28, 2025

Nuveen Asset Management LLC Lowers Position in NovoCure Limited (NASDAQ:NVCR) - Defense World

May 28, 2025

May 27, 2025

Novocure Announces Upcoming Investor Events | NVCR Stock News - GuruFocus

May 27, 2025

May 27, 2025

Novocure Announces Upcoming Investor Events - Yahoo Finance

May 27, 2025

May 22, 2025

Is NovoCure (NASDAQ:NVCR) Using Debt Sensibly? - simplywall.st

May 22, 2025

May 22, 2025

BNP Paribas Financial Markets Sells 147,371 Shares of NovoCure Limited (NASDAQ:NVCR) - Defense World

May 22, 2025

May 17, 2025

Dimensional Fund Advisors LP Sells 3,016 Shares of NovoCure Limited (NASDAQ:NVCR) - Defense World

May 17, 2025

May 15, 2025

Does NovoCure (NVCR) Have the Potential to Rally 105.5% as Wall Street Analysts Expect? - Yahoo Finance

May 15, 2025

May 12, 2025

Tower Research Capital LLC TRC Sells 6,669 Shares of NovoCure Limited (NASDAQ:NVCR) - Defense World

May 12, 2025

May 11, 2025

Raymond James Financial Inc. Purchases Shares of 11,672 NovoCure Limited (NASDAQ:NVCR) - Defense World

May 11, 2025

May 10, 2025

Investor Network: Novocure Ltd. to Host Earnings Call - ACCESS Newswire

May 10, 2025

May 10, 2025

NovoCure Limited (NASDAQ:NVCR) Given Average Rating of “Moderate Buy” by Analysts - Defense World

May 10, 2025

May 09, 2025

NovoCure Ltd (NVCR)’s Market Momentum: Closing Strong at 20.62, Down -3.28 - DWinneX

May 09, 2025

May 07, 2025

Envestnet Asset Management Inc. Buys New Holdings in NovoCure Limited (NASDAQ:NVCR) - Defense World

May 07, 2025

May 07, 2025

Mariner LLC Acquires Shares of 8,631 NovoCure Limited (NASDAQ:NVCR) - Defense World

May 07, 2025

May 06, 2025

Comparing Meihua International Medical Technologies (NASDAQ:MHUA) & NovoCure (NASDAQ:NVCR) - Defense World

May 06, 2025

May 02, 2025

Ratio Analysis: Unpacking NovoCure Ltd (NVCR)’s Price-to-Cash and Price-to-Free Cash Flow - DWinneX

May 02, 2025

May 02, 2025

A year in review: NovoCure Ltd (NVCR)’s performance in the last year - uspostnews.com

May 02, 2025

Apr 29, 2025

Wall Street Analysts See a 91.92% Upside in NovoCure (NVCR): Can the Stock Really Move This High? - Yahoo Finance

Apr 29, 2025

Apr 29, 2025

NovoCure Ltd’s latest rating changes from various analysts - knoxdaily.com

Apr 29, 2025

Apr 28, 2025

What is NovoCure Ltd (NVCR) Stock Return on Shareholders’ Capital? - Sete News

Apr 28, 2025

Apr 28, 2025

Russell Investments Group Ltd. Sells 2,135 Shares of NovoCure Limited (NASDAQ:NVCR) - Defense World

Apr 28, 2025

Apr 26, 2025

NovoCure First Quarter 2025 Earnings: Beats Expectations - simplywall.st

Apr 26, 2025

Apr 25, 2025

H.C. Wainwright maintains Buy on NovoCure, $38 price target By Investing.com - Investing.com Canada

Apr 25, 2025

Apr 25, 2025

NovoCure Ltd [NVCR] Shares Jump Approximately 56.80% Over the Year - knoxdaily.com

Apr 25, 2025